Genetic testing for hereditary breast and ovarian cancer (HBOC) is evolving rapidly, owing to the recent introduction of multigene panels. Compared with testing for BRCA1/BRCA2 alone, these tests identify a greater number of individuals with genetic mutations. This study addresses how often and in which ways the identification of non-BRCA1/2 mutations would alter clinical management under current practice guidelines.
▪ Most (92%) of the non-BRCA1/2 mutations were consistent with the spectrum of cancer(s) observed in the patient/family, suggesting that these results are clinically relevant and not incidental.
▪ Additional screening or prevention measures-over and above any recommendations based on personal and family history alone-would be considered for the majority (52%) of the non-BRCA1/2-positive patients (Table 1) .
▪ Testing of most (72%) first-degree relatives of the non-BRCA1/2-positive patients would also be indicated based on the potential management changes for those individuals (Table 1) .
▪ Clinical impact was not restricted to a few of the tested genes: most genes with positive results had the potential to change management for at least some patients in this study.
DISCUSSION:
In a clinically representative cohort, we found that multigene panel testing for HBOC yields clinically actionable findings across a broad spectrum of cancer risk genes. Compared with the results of BRCA1/2 testing alone, these findings are likely to change risk assessment and management for substantially more patients and their family members under current practice guidelines. 
Figure 1: Representative pedigrees
A. With an MSH6 mutation in this patient (indicated by black triangle) with breast cancer and a family history of breast, colon, uterine, and bladder cancer, screening for colorectal, gynecologic, and urologic cancers would be indicated; prophylactic gynecologic surgery could be considered, and additional family member testing is recommended and could provide indication for enhanced screening and possibly preventive surgery. 
